Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$25.5 - $31.51 $264,435 - $326,758
10,370 New
10,370 $296,000
Q4 2023

Feb 12, 2024

SELL
$26.32 - $34.31 $8,159 - $10,636
-310 Reduced 4.7%
6,280 $211,000
Q3 2023

Nov 13, 2023

BUY
$30.68 - $40.09 $3,988 - $5,211
130 Added 2.01%
6,590 $202,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $47.5 $8,307 - $10,925
230 Added 3.69%
6,460 $258,000
Q1 2023

Apr 21, 2023

BUY
$35.53 - $43.38 $14,389 - $17,568
405 Added 6.95%
6,230 $254,000
Q4 2022

Feb 03, 2023

BUY
$38.19 - $57.45 $14,130 - $21,256
370 Added 6.78%
5,825 $224,000
Q3 2022

Oct 19, 2022

BUY
$51.24 - $58.89 $279,514 - $321,244
5,455 New
5,455 $290,000
Q1 2022

May 06, 2022

SELL
$60.03 - $76.49 $6,003 - $7,648
-100 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$47.97 - $62.21 $4,797 - $6,221
100 New
100 $6,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Retirement Planning CO Of New England, Inc. Portfolio

Follow Retirement Planning CO Of New England, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning CO Of New England, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning CO Of New England, Inc. with notifications on news.